| Wed, Jul 8, 2009 | | | StreetInvesting.com Free Research on SGMS, SIAL, ASTM, CAEI, ALKS and CORS Marketwire (Wed, Jul 8)
| | Mon, Jul 6, 2009 | | | Geron Study Result Pushes Shares Higher Indie Research (Mon, Jul 6)
| | Wed, Jul 1, 2009 | | | GE to Obtain Stem Cells From Geron For Research at The Wall Street Journal Online (Wed, Jul 1)
| | Tue, Jun 30, 2009 | | | UPDATE - GE teams up with Geron for stem-cell research at Reuters (Tue, Jun 30)
| | | Closing Update for Tuesday June 30 at Seeking Alpha (Tue, Jun 30)
| | | Geron and GE Alliance Sends Stem Cell Stocks Higher Indie Research (Tue, Jun 30)
| | Fri, Jun 19, 2009 | | | Biotech Stocks: Drug stocks diverge from broader market at MarketWatch (Fri, Jun 19)
| | | Biotech Stocks: Drug stocks move higher with broader market at MarketWatch (Fri, Jun 19)
| | Thu, Jun 18, 2009 | | | Biotech Stocks: Drug stocks gain; Aastrom rallies on FDA nod at MarketWatch (Thu, Jun 18)
| | | Aastrom says FDA lifts stem cell trial halt AP (Thu, Jun 18)
| | | Biotech Stocks: Drug stocks mixed; Aastrom rallies on FDA nod at MarketWatch (Thu, Jun 18)
| | | FDA Action Sends Stem Cell Stocks Moving Indie Research (Thu, Jun 18)
| | | FDA allows Aastrom stem-cell study to resume at MarketWatch (Thu, Jun 18)
| | | UPDATE - Aastrom: FDA lifts clinical hold from heart study at Reuters (Thu, Jun 18)
| | | FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial GlobeNewswire (Thu, Jun 18)
| | Fri, Jun 12, 2009 | | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S EDGAR Online (Fri, Jun 12)
| | Mon, Jun 8, 2009 | | | Selected Healthcare Sectors Buck Market Dip Indie Research (Mon, Jun 8)
| | Wed, May 27, 2009 | | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and EDGAR Online (Wed, May 27)
| | Fri, May 22, 2009 | | | Aastrom suspends trial following death of patient AP (Fri, May 22)
| | | Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event GlobeNewswire (Fri, May 22)
| Add ASTM News to My Yahoo!:

| |
|